APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCI and EEG

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.

An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.

Selected research

Market Outlook & Growth Opportunities

Global BCI and EEG Market Outlook and Growth Opportunities 2026

1 January 2026219 pages

Choose your research edition.

Industry ResearchBCI and EEG Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal BCI and EEG Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal BCI and EEG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCI and EEG Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal BCI and EEG Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.

An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.

Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.

Read the full market overview

This report provides an overview of the global BCI and EEG market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of BCI and EEG and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BCI and EEG revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global BCI and EEG market.

BCI and EEG Segment by Company

Medtronic

Natus Medical

Nihon Kohden

NeuroPace Inc

Mindmaze SA

G.TEC

BrainCo

InteraXon

Brain Products GmbH

EGI

Blackrock Microsystems LLC

Emotiv Inc

Micromed

ANT Neuro B.V

Compumedics Limited

NeuroSky, Inc.

Artinis Medical Systems BV

Cadwell

Advanced Brain Monitoring

NCC Medical

SYMTOP

Neuroelectrics

BCI and EEG Segment by Type

Hardware

Software and Service

BCI and EEG Segment by Application

Medical

Consumer

BCI and EEG Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global BCI and EEG status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the BCI and EEG key companies, revenue, market share, and recent developments.

3. To split the BCI and EEG breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions BCI and EEG market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify BCI and EEG significant trends, drivers, influence factors in global and regions.

6. To analyze BCI and EEG competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCI and EEG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCI and EEG and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCI and EEG.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BCI and EEG industry.

Chapter 3: Detailed analysis of BCI and EEG company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of BCI and EEG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of BCI and EEG in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. BCI and EEG Industry Trends Table 2. BCI and EEG Industry Drivers Table 3. BCI and EEG Industry Opportunities and Challenges Table 4. BCI and EEG Industry Restraints Table 5. Global BCI and EEG Revenue by Company (US$ Million) & (2021-2026) Table 6. Global BCI and EEG Revenue Share by Company (2021-2026) Table 7. Global BCI and EEG Company Ranking, (2024-2026) & (US$ Million) Table 8. Global BCI and EEG Key Company Manufacturing Base & Headquarters Table 9. Global BCI and EEG Company, Product Type & Application Table 10. Global BCI and EEG Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global BCI and EEG by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Table 15. Significant Companies of Software and Service Table 16. Global BCI and EEG Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global BCI and EEG Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global BCI and EEG Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global BCI and EEG Sales Value Share by Type (2021-2026) Table 20. Global BCI and EEG Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Table 22. Significant Companies of Consumer Table 23. Global BCI and EEG Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global BCI and EEG Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global BCI and EEG Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global BCI and EEG Sales Value Share by Application (2021-2026) Table 27. Global BCI and EEG Sales Value Share by Application (2027-2032) Table 28. Global BCI and EEG Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global BCI and EEG Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global BCI and EEG Sales Value Share by Region (2021-2026) Table 31. Global BCI and EEG Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global BCI and EEG Sales Value Share by Region (2027-2032) Table 33. Global BCI and EEG Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global BCI and EEG Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global BCI and EEG Sales Value Market Share by Country (2021-2026) Table 36. Global BCI and EEG Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global BCI and EEG Sales Value Market Share by Country (2027-2032) Table 38. Medtronic Company Information Table 39. Medtronic Business Overview Table 40. Medtronic BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Medtronic BCI and EEG Product Portfolio Table 42. Medtronic Recent Development Table 43. Natus Medical Company Information Table 44. Natus Medical Business Overview Table 45. Natus Medical BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Natus Medical BCI and EEG Product Portfolio Table 47. Natus Medical Recent Development Table 48. Nihon Kohden Company Information Table 49. Nihon Kohden Business Overview Table 50. Nihon Kohden BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Nihon Kohden BCI and EEG Product Portfolio Table 52. Nihon Kohden Recent Development Table 53. NeuroPace Inc Company Information Table 54. NeuroPace Inc Business Overview Table 55. NeuroPace Inc BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. NeuroPace Inc BCI and EEG Product Portfolio Table 57. NeuroPace Inc Recent Development Table 58. Mindmaze SA Company Information Table 59. Mindmaze SA Business Overview Table 60. Mindmaze SA BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Mindmaze SA BCI and EEG Product Portfolio Table 62. Mindmaze SA Recent Development Table 63. G.TEC Company Information Table 64. G.TEC Business Overview Table 65. G.TEC BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. G.TEC BCI and EEG Product Portfolio Table 67. G.TEC Recent Development Table 68. BrainCo Company Information Table 69. BrainCo Business Overview Table 70. BrainCo BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BrainCo BCI and EEG Product Portfolio Table 72. BrainCo Recent Development Table 73. InteraXon Company Information Table 74. InteraXon Business Overview Table 75. InteraXon BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. InteraXon BCI and EEG Product Portfolio Table 77. InteraXon Recent Development Table 78. Brain Products GmbH Company Information Table 79. Brain Products GmbH Business Overview Table 80. Brain Products GmbH BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Brain Products GmbH BCI and EEG Product Portfolio Table 82. Brain Products GmbH Recent Development Table 83. EGI Company Information Table 84. EGI Business Overview Table 85. EGI BCI and EEG Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. EGI BCI and EEG Product Portfolio Table 87. EGI Recent Development Table 88. Blackrock Microsystems LLC Company Information Table 89. Blackrock Microsystems LLC Business Overview Table 90. Blackrock Microsystems LLC BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Blackrock Microsystems LLC BCI and EEG Product Portfolio Table 92. Blackrock Microsystems LLC Recent Development Table 93. Emotiv Inc Company Information Table 94. Emotiv Inc Business Overview Table 95. Emotiv Inc BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Emotiv Inc BCI and EEG Product Portfolio Table 97. Emotiv Inc Recent Development Table 98. Micromed Company Information Table 99. Micromed Business Overview Table 100. Micromed BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Micromed BCI and EEG Product Portfolio Table 102. Micromed Recent Development Table 103. ANT Neuro B.V Company Information Table 104. ANT Neuro B.V Business Overview Table 105. ANT Neuro B.V BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ANT Neuro B.V BCI and EEG Product Portfolio Table 107. ANT Neuro B.V Recent Development Table 108. Compumedics Limited Company Information Table 109. Compumedics Limited Business Overview Table 110. Compumedics Limited BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Compumedics Limited BCI and EEG Product Portfolio Table 112. Compumedics Limited Recent Development Table 113. NeuroSky, Inc. Company Information Table 114. NeuroSky, Inc. Business Overview Table 115. NeuroSky, Inc. BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. NeuroSky, Inc. BCI and EEG Product Portfolio Table 117. NeuroSky, Inc. Recent Development Table 118. Artinis Medical Systems BV Company Information Table 119. Artinis Medical Systems BV Business Overview Table 120. Artinis Medical Systems BV BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Artinis Medical Systems BV BCI and EEG Product Portfolio Table 122. Artinis Medical Systems BV Recent Development Table 123. Cadwell Company Information Table 124. Cadwell Business Overview Table 125. Cadwell BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Cadwell BCI and EEG Product Portfolio Table 127. Cadwell Recent Development Table 128. Advanced Brain Monitoring Company Information Table 129. Advanced Brain Monitoring Business Overview Table 130. Advanced Brain Monitoring BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Advanced Brain Monitoring BCI and EEG Product Portfolio Table 132. Advanced Brain Monitoring Recent Development Table 133. NCC Medical Company Information Table 134. NCC Medical Business Overview Table 135. NCC Medical BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. NCC Medical BCI and EEG Product Portfolio Table 137. NCC Medical Recent Development Table 138. SYMTOP Company Information Table 139. SYMTOP Business Overview Table 140. SYMTOP BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. SYMTOP BCI and EEG Product Portfolio Table 142. SYMTOP Recent Development Table 143. Neuroelectrics Company Information Table 144. Neuroelectrics Business Overview Table 145. Neuroelectrics BCI and EEG Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Neuroelectrics BCI and EEG Product Portfolio Table 147. Neuroelectrics Recent Development Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. BCI and EEG Product Image Figure 2. Global BCI and EEG Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCI and EEG Market Size (2021-2032) & (US$ Million) Figure 4. Global BCI and EEG Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Image Figure 8. Software and Service Image Figure 9. Global BCI and EEG Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global BCI and EEG Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global BCI and EEG Sales Value Share by Type (2021-2032) Figure 12. Medical Image Figure 13. Consumer Image Figure 14. Global BCI and EEG Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global BCI and EEG Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global BCI and EEG Sales Value Share by Application (2021-2032) Figure 17. Global BCI and EEG Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global BCI and EEG Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America BCI and EEG Sales Value (2021-2032) & (US$ Million) Figure 20. North America BCI and EEG Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe BCI and EEG Sales Value (2021-2032) & (US$ Million) Figure 22. Europe BCI and EEG Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific BCI and EEG Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific BCI and EEG Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America BCI and EEG Sales Value (2021-2032) & (US$ Million) Figure 26. South America BCI and EEG Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa BCI and EEG Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa BCI and EEG Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt BCI and EEG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt BCI and EEG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt BCI and EEG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software and Service
Applications
  • Medical
  • Consumer
Companies covered
  • Medtronic
  • Natus Medical
  • Nihon Kohden
  • NeuroPace Inc
  • Mindmaze SA
  • G.TEC
  • BrainCo
  • InteraXon
  • Brain Products GmbH
  • EGI
  • Blackrock Microsystems LLC
  • Emotiv Inc
  • Micromed
  • ANT Neuro B.V
  • Compumedics Limited
  • NeuroSky, Inc.
  • Artinis Medical Systems BV
  • Cadwell
  • Advanced Brain Monitoring
  • NCC Medical
  • SYMTOP
  • Neuroelectrics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global BCI and EEG Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global BCI and EEG Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 BCI and EEG Market Dynamics
  1. 2.1 BCI and EEG Industry Trends
  2. 2.2 BCI and EEG Industry Drivers
  3. 2.3 BCI and EEG Industry Opportunities and Challenges
  4. 2.4 BCI and EEG Industry Restraints
3 BCI and EEG Market by Company
  1. 3.1 Global BCI and EEG Company Revenue Ranking in 2025
  2. 3.2 Global BCI and EEG Revenue by Company (2021-2026)
  3. 3.3 Global BCI and EEG Company Ranking (2024-2026)
  4. 3.4 Global BCI and EEG Company Manufacturing Base and Headquarters
  5. 3.5 Global BCI and EEG Company Product Type and Application
  6. 3.6 Global BCI and EEG Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global BCI and EEG Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 BCI and EEG Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 BCI and EEG Market by Type
  1. 4.1 BCI and EEG Type Introduction
  2. 4.1.1 Hardware
  3. 4.1.2 Software and Service
  4. 4.2 Global BCI and EEG Sales Value by Type
  5. 4.2.1 Global BCI and EEG Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BCI and EEG Sales Value by Type (2021-2032)
  7. 4.2.3 Global BCI and EEG Sales Value Share by Type (2021-2032)
5 BCI and EEG Market by Application
  1. 5.1 BCI and EEG Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Consumer
  4. 5.2 Global BCI and EEG Sales Value by Application
  5. 5.2.1 Global BCI and EEG Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global BCI and EEG Sales Value by Application (2021-2032)
  7. 5.2.3 Global BCI and EEG Sales Value Share by Application (2021-2032)
6 BCI and EEG Regional Value Analysis
  1. 6.1 Global BCI and EEG Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BCI and EEG Sales Value by Region (2021-2032)
  3. 6.2.1 Global BCI and EEG Sales Value by Region: 2021-2026
  4. 6.2.2 Global BCI and EEG Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America BCI and EEG Sales Value (2021-2032)
  7. 6.3.2 North America BCI and EEG Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe BCI and EEG Sales Value (2021-2032)
  10. 6.4.2 Europe BCI and EEG Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific BCI and EEG Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific BCI and EEG Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America BCI and EEG Sales Value (2021-2032)
  16. 6.6.2 South America BCI and EEG Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa BCI and EEG Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa BCI and EEG Sales Value Share by Country, 2025 VS 2032
7 BCI and EEG Country-level Value Analysis
  1. 7.1 Global BCI and EEG Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global BCI and EEG Sales Value by Country (2021-2032)
  3. 7.2.1 Global BCI and EEG Sales Value by Country (2021-2026)
  4. 7.2.2 Global BCI and EEG Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA BCI and EEG Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA BCI and EEG Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA BCI and EEG Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada BCI and EEG Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada BCI and EEG Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada BCI and EEG Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico BCI and EEG Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico BCI and EEG Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico BCI and EEG Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany BCI and EEG Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany BCI and EEG Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany BCI and EEG Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France BCI and EEG Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France BCI and EEG Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France BCI and EEG Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. BCI and EEG Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. BCI and EEG Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. BCI and EEG Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy BCI and EEG Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy BCI and EEG Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy BCI and EEG Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain BCI and EEG Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain BCI and EEG Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain BCI and EEG Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia BCI and EEG Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia BCI and EEG Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia BCI and EEG Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands BCI and EEG Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands BCI and EEG Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands BCI and EEG Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries BCI and EEG Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries BCI and EEG Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries BCI and EEG Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China BCI and EEG Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China BCI and EEG Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China BCI and EEG Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan BCI and EEG Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan BCI and EEG Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan BCI and EEG Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea BCI and EEG Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea BCI and EEG Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea BCI and EEG Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India BCI and EEG Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India BCI and EEG Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India BCI and EEG Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia BCI and EEG Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia BCI and EEG Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia BCI and EEG Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia BCI and EEG Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia BCI and EEG Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia BCI and EEG Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil BCI and EEG Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil BCI and EEG Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil BCI and EEG Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina BCI and EEG Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina BCI and EEG Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina BCI and EEG Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile BCI and EEG Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile BCI and EEG Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile BCI and EEG Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia BCI and EEG Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia BCI and EEG Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia BCI and EEG Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru BCI and EEG Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru BCI and EEG Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru BCI and EEG Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia BCI and EEG Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia BCI and EEG Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia BCI and EEG Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel BCI and EEG Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel BCI and EEG Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel BCI and EEG Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE BCI and EEG Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE BCI and EEG Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE BCI and EEG Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey BCI and EEG Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey BCI and EEG Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey BCI and EEG Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran BCI and EEG Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran BCI and EEG Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran BCI and EEG Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt BCI and EEG Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt BCI and EEG Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt BCI and EEG Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic BCI and EEG Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic BCI and EEG Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Natus Medical
  8. 8.2.1 Natus Medical Company Information
  9. 8.2.2 Natus Medical Business Overview
  10. 8.2.3 Natus Medical BCI and EEG Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Natus Medical BCI and EEG Product Portfolio
  12. 8.2.5 Natus Medical Recent Developments
  13. 8.3 Nihon Kohden
  14. 8.3.1 Nihon Kohden Company Information
  15. 8.3.2 Nihon Kohden Business Overview
  16. 8.3.3 Nihon Kohden BCI and EEG Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nihon Kohden BCI and EEG Product Portfolio
  18. 8.3.5 Nihon Kohden Recent Developments
  19. 8.4 NeuroPace Inc
  20. 8.4.1 NeuroPace Inc Company Information
  21. 8.4.2 NeuroPace Inc Business Overview
  22. 8.4.3 NeuroPace Inc BCI and EEG Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NeuroPace Inc BCI and EEG Product Portfolio
  24. 8.4.5 NeuroPace Inc Recent Developments
  25. 8.5 Mindmaze SA
  26. 8.5.1 Mindmaze SA Company Information
  27. 8.5.2 Mindmaze SA Business Overview
  28. 8.5.3 Mindmaze SA BCI and EEG Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mindmaze SA BCI and EEG Product Portfolio
  30. 8.5.5 Mindmaze SA Recent Developments
  31. 8.6 G.TEC
  32. 8.6.1 G.TEC Company Information
  33. 8.6.2 G.TEC Business Overview
  34. 8.6.3 G.TEC BCI and EEG Revenue and Gross Margin (2021-2026)
  35. 8.6.4 G.TEC BCI and EEG Product Portfolio
  36. 8.6.5 G.TEC Recent Developments
  37. 8.7 BrainCo
  38. 8.7.1 BrainCo Company Information
  39. 8.7.2 BrainCo Business Overview
  40. 8.7.3 BrainCo BCI and EEG Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BrainCo BCI and EEG Product Portfolio
  42. 8.7.5 BrainCo Recent Developments
  43. 8.8 InteraXon
  44. 8.8.1 InteraXon Company Information
  45. 8.8.2 InteraXon Business Overview
  46. 8.8.3 InteraXon BCI and EEG Revenue and Gross Margin (2021-2026)
  47. 8.8.4 InteraXon BCI and EEG Product Portfolio
  48. 8.8.5 InteraXon Recent Developments
  49. 8.9 Brain Products GmbH
  50. 8.9.1 Brain Products GmbH Company Information
  51. 8.9.2 Brain Products GmbH Business Overview
  52. 8.9.3 Brain Products GmbH BCI and EEG Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Brain Products GmbH BCI and EEG Product Portfolio
  54. 8.9.5 Brain Products GmbH Recent Developments
  55. 8.10 EGI
  56. 8.10.1 EGI Company Information
  57. 8.10.2 EGI Business Overview
  58. 8.10.3 EGI BCI and EEG Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EGI BCI and EEG Product Portfolio
  60. 8.10.5 EGI Recent Developments
  61. 8.11 Blackrock Microsystems LLC
  62. 8.11.1 Blackrock Microsystems LLC Company Information
  63. 8.11.2 Blackrock Microsystems LLC Business Overview
  64. 8.11.3 Blackrock Microsystems LLC BCI and EEG Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Blackrock Microsystems LLC BCI and EEG Product Portfolio
  66. 8.11.5 Blackrock Microsystems LLC Recent Developments
  67. 8.12 Emotiv Inc
  68. 8.12.1 Emotiv Inc Company Information
  69. 8.12.2 Emotiv Inc Business Overview
  70. 8.12.3 Emotiv Inc BCI and EEG Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Emotiv Inc BCI and EEG Product Portfolio
  72. 8.12.5 Emotiv Inc Recent Developments
  73. 8.13 Micromed
  74. 8.13.1 Micromed Company Information
  75. 8.13.2 Micromed Business Overview
  76. 8.13.3 Micromed BCI and EEG Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Micromed BCI and EEG Product Portfolio
  78. 8.13.5 Micromed Recent Developments
  79. 8.14 ANT Neuro B.V
  80. 8.14.1 ANT Neuro B.V Company Information
  81. 8.14.2 ANT Neuro B.V Business Overview
  82. 8.14.3 ANT Neuro B.V BCI and EEG Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ANT Neuro B.V BCI and EEG Product Portfolio
  84. 8.14.5 ANT Neuro B.V Recent Developments
  85. 8.15 Compumedics Limited
  86. 8.15.1 Compumedics Limited Company Information
  87. 8.15.2 Compumedics Limited Business Overview
  88. 8.15.3 Compumedics Limited BCI and EEG Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Compumedics Limited BCI and EEG Product Portfolio
  90. 8.15.5 Compumedics Limited Recent Developments
  91. 8.16 NeuroSky, Inc.
  92. 8.16.1 NeuroSky, Inc. Company Information
  93. 8.16.2 NeuroSky, Inc. Business Overview
  94. 8.16.3 NeuroSky, Inc. BCI and EEG Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NeuroSky, Inc. BCI and EEG Product Portfolio
  96. 8.16.5 NeuroSky, Inc. Recent Developments
  97. 8.17 Artinis Medical Systems BV
  98. 8.17.1 Artinis Medical Systems BV Company Information
  99. 8.17.2 Artinis Medical Systems BV Business Overview
  100. 8.17.3 Artinis Medical Systems BV BCI and EEG Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Artinis Medical Systems BV BCI and EEG Product Portfolio
  102. 8.17.5 Artinis Medical Systems BV Recent Developments
  103. 8.18 Cadwell
  104. 8.18.1 Cadwell Company Information
  105. 8.18.2 Cadwell Business Overview
  106. 8.18.3 Cadwell BCI and EEG Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cadwell BCI and EEG Product Portfolio
  108. 8.18.5 Cadwell Recent Developments
  109. 8.19 Advanced Brain Monitoring
  110. 8.19.1 Advanced Brain Monitoring Company Information
  111. 8.19.2 Advanced Brain Monitoring Business Overview
  112. 8.19.3 Advanced Brain Monitoring BCI and EEG Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Advanced Brain Monitoring BCI and EEG Product Portfolio
  114. 8.19.5 Advanced Brain Monitoring Recent Developments
  115. 8.20 NCC Medical
  116. 8.20.1 NCC Medical Company Information
  117. 8.20.2 NCC Medical Business Overview
  118. 8.20.3 NCC Medical BCI and EEG Revenue and Gross Margin (2021-2026)
  119. 8.20.4 NCC Medical BCI and EEG Product Portfolio
  120. 8.20.5 NCC Medical Recent Developments
  121. 8.21 SYMTOP
  122. 8.21.1 SYMTOP Company Information
  123. 8.21.2 SYMTOP Business Overview
  124. 8.21.3 SYMTOP BCI and EEG Revenue and Gross Margin (2021-2026)
  125. 8.21.4 SYMTOP BCI and EEG Product Portfolio
  126. 8.21.5 SYMTOP Recent Developments
  127. 8.22 Neuroelectrics
  128. 8.22.1 Neuroelectrics Company Information
  129. 8.22.2 Neuroelectrics Business Overview
  130. 8.22.3 Neuroelectrics BCI and EEG Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Neuroelectrics BCI and EEG Product Portfolio
  132. 8.22.5 Neuroelectrics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst